IDEX BIOMETRICS ASA -ADR (IDBA) Stock Analyst Earnings Estimates
NASDAQ:IDBA - Nasdaq - US45173W1053 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.095M 158.87% | 2.84M 159.36% | 4.091M 44.05% | 187.77M 4,489.83% | 960.11M 411.32% | 3.202B 233.50% | |
| EBITDA YoY % growth | -24.683M 18.84% | -29.548M -19.71% | -30.017M -1.59% | -201.001M -569.62% | 139.97M 169.64% | 942.84M 573.60% | |
| EBIT YoY % growth | -26.402M 17.61% | -31.35M -18.74% | -31.369M -0.06% | -238.608M -660.65% | 96.925M 140.62% | 898.47M 826.97% | |
| Operating Margin | -2,411.14% | -1,103.87% | -766.78% | -127.07% | 10.10% | 28.06% | |
| EPS YoY % growth | -23.45 | N/A 24.75% | N/A | -13.92 21.12% | -94.82 -581.36% | 41.49 143.75% |
All data in USD
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -274.06 -41,044.79% | -203.79 |
| Revenue Q2Q % growth | 21.128M 2,176.72% | 42.256M 3,863.98% |
| EBITDA Q2Q % growth | -56.411M -696.21% | -41.199M -637.41% |
| EBIT Q2Q % growth | -63.701M -684.39% | -48.436M -598.02% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.67 | -274.06 | 273.40 | 99.76% |
| Q1 2023 Q2Q % growth | -6.79 | -288.12 | 281.33 | 97.65% |
| Q4 2022 Q2Q % growth | 0.00 100.00% | % | ||
| Q4 2021 Q2Q % growth | -1.33 77.78% | % | ||
| Q2 2021 Q2Q % growth | -0.67 88.51% | % | ||
| Q1 2021 Q2Q % growth | -5.66 -1.19% | % | ||
| Q2 2020 Q2Q % growth | -5.79 20.80% | % | ||
| Q1 2020 Q2Q % growth | -5.60 29.91% | % | ||
| Q2 2019 Q2Q % growth | -7.32 | 6.79 | -14.10 | -207.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 1,616.16% | 19.015M | % | |
| Q1 2023 Q2Q % growth | 1.242M 25.58% | 15.846M | -14.604M | -92.16% |
| Q4 2022 Q2Q % growth | 1.066M 35.45% | % | ||
| Q3 2022 Q2Q % growth | 928K 26.78% | % | ||
| Q2 2022 Q2Q % growth | 1.108M 58.97% | % | ||
| Q1 2022 Q2Q % growth | 989K 58.49% | % | ||
| Q4 2021 Q2Q % growth | 787K 31.61% | % | ||
| Q3 2021 Q2Q % growth | 732K 195.16% | % | ||
| Q2 2021 Q2Q % growth | 697K 367.79% | % | ||
| Q1 2021 Q2Q % growth | 624K 524.00% | % | ||
| Q4 2020 Q2Q % growth | 598K 742.25% | % | ||
| Q3 2020 Q2Q % growth | 248K 66.44% | % | ||
| Q2 2020 Q2Q % growth | 149K 246.51% | % | ||
| Q1 2020 Q2Q % growth | 100K -27.65% | % | ||
| Q2 2019 Q2Q % growth | 43K | 3.06M | -3.017M | -98.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.29% | -14.9% | 2.29% | -14.9% |
| Revenue | 0% | 0% | -10.69% | -10.69% |